These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 23897874)

  • 41. [Therapeutic measures in tardive dyskinesia].
    Tegeler J; Wöller W
    Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Suchowersky O; Gronseth G; Perlmutter J; Reich S; Zesiewicz T; Weiner WJ;
    Neurology; 2006 Apr; 66(7):976-82. PubMed ID: 16606908
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology.
    Yadav V; Bever C; Bowen J; Bowling A; Weinstock-Guttman B; Cameron M; Bourdette D; Gronseth GS; Narayanaswami P
    Neurology; 2014 Mar; 82(12):1083-92. PubMed ID: 24663230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Re: Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Stricker RB; Johnson L
    Neurology; 2008 May; 70(19):1719; author reply 1719-20. PubMed ID: 18458234
    [No Abstract]   [Full Text] [Related]  

  • 45. Practice parameter: therapies for benign paroxysmal positional vertigo (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Fife TD; Iverson DJ; Lempert T; Furman JM; Baloh RW; Tusa RJ; Hain TC; Herdman S; Morrow MJ; Gronseth GS;
    Neurology; 2008 May; 70(22):2067-74. PubMed ID: 18505980
    [No Abstract]   [Full Text] [Related]  

  • 46. Identification and management of tardive dyskinesia: A case series and literature review.
    Khouzam HR
    Postgrad Med; 2015; 127(7):726-37. PubMed ID: 26216578
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    Krumholz A; Wiebe S; Gronseth GS; Gloss DS; Sanchez AM; Kabir AA; Liferidge AT; Martello JP; Kanner AM; Shinnar S; Hopp JL; French JA
    Neurology; 2015 Apr; 84(16):1705-13. PubMed ID: 25901057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment: use of epidural steroid injections to treat radicular lumbosacral pain: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Manchikanti L; Boswell MV; Giordano J; Kaplan E
    Neurology; 2007 Sep; 69(11):1190; author reply 1190-1. PubMed ID: 17846419
    [No Abstract]   [Full Text] [Related]  

  • 49. Evidence-based guideline: Treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Burneo JG; Escalaya AL
    Neurology; 2013 Oct; 81(16):1474. PubMed ID: 24127192
    [No Abstract]   [Full Text] [Related]  

  • 50. Evidence-based guideline: Treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Sethi NK
    Neurology; 2013 Oct; 81(16):1475-6. PubMed ID: 24278969
    [No Abstract]   [Full Text] [Related]  

  • 51. Evidence-based guideline: Treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Gonzalez-Duarte A
    Neurology; 2013 Oct; 81(16):1474-5. PubMed ID: 24278968
    [No Abstract]   [Full Text] [Related]  

  • 52. Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome.
    Esquenazi A; Albanese A; Chancellor MB; Elovic E; Segal KR; Simpson DM; Smith CP; Ward AB
    Toxicon; 2013 Jun; 67():115-28. PubMed ID: 23220492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Practice parameter: the evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation.
    England JD; Gronseth GS; Franklin G; Carter GT; Kinsella LJ; Cohen JA; Asbury AK; Szigeti K; Lupski JR; Latov N; Lewis RA; Low PA; Fisher MA; Herrmann D; Howard JF; Lauria G; Miller RG; Polydefkis M; Sumner AJ; ; ;
    PM R; 2009 Jan; 1(1):14-22. PubMed ID: 19627868
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders.
    Naumann M; Dressler D; Hallett M; Jankovic J; Schiavo G; Segal KR; Truong D
    Toxicon; 2013 Jun; 67():141-52. PubMed ID: 23178324
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Practice parameter: the evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation.
    England JD; Gronseth GS; Franklin G; Carter GT; Kinsella LJ; Cohen JA; Asbury AK; Szigeti K; Lupski JR; Latov N; Lewis RA; Low PA; Fisher MA; Herrmann DN; Howard JF; Lauria G; Miller RG; Polydefkis M; Sumner AJ; ; ;
    PM R; 2009 Jan; 1(1):5-13. PubMed ID: 19627867
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Simpson DM; Gracies JM; Graham HK; Miyasaki JM; Naumann M; Russman B; Simpson LL; So Y;
    Neurology; 2008 May; 70(19):1691-8. PubMed ID: 18458229
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence-based review and assessment of botulinum neurotoxin for the treatment of urologic conditions.
    Chancellor MB; Elovic E; Esquenazi A; Naumann M; Segal KR; Schiavo G; Smith CP; Ward AB
    Toxicon; 2013 Jun; 67():129-40. PubMed ID: 23415704
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tardive dyskinesia.
    Clyne KE; Juhl R
    Am J Hosp Pharm; 1976 May; 33(5):481-6. PubMed ID: 1274963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quality improvement in neurology: AAN epilepsy quality measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology.
    Fountain NB; Van Ness PC; Swain-Eng R; Tonn S; Bever CT;
    Neurology; 2011 Jan; 76(1):94-9. PubMed ID: 21205698
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Summary of evidence-based guideline: Periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease: report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Khoo KF; Lepas B
    Neurology; 2014 Jan; 82(1):95. PubMed ID: 24379098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.